Lab test

STD Test Panel w/ Early Detection HIV RNA

The Early Detection Comprehensive Panel combines screening for several sexually transmitted infections into one visit, including an early-detection HIV RNA test and trichomoniasis testing.

Typical price

From $375

Results

1-3 business days

Preparation

See preparation notes below

Sample

Blood draw or sample collection at a local center

The Early Detection Comprehensive Panel combines screening for several sexually transmitted infections into one visit, including an early-detection HIV RNA test and trichomoniasis testing. It is designed for people who want a broad sexual health check, especially after a recent possible exposure when some antibody-based tests may not yet detect infection. Testing multiple organisms together provides a convenient overview of sexual health status. Results are screening information that should be reviewed with a healthcare provider, who can interpret them in the context of timing and symptoms.

• HIV RNA (early detection) Detects HIV genetic material directly and can identify infection sooner than antibody-only tests.
• Trichomonas vaginalis Identifies the parasite that causes trichomoniasis.
• Chlamydia trachomatis Detects the bacterium that causes chlamydia.
• Neisseria gonorrhoeae Detects the bacterium that causes gonorrhea.
• Treponema pallidum (syphilis) Screens for the bacterium that causes syphilis.
• Hepatitis B virus Screens for markers of hepatitis B infection.
• Hepatitis C virus Screens for antibodies associated with hepatitis C infection.

• People who may have had a recent exposure and want early detection
• Individuals with new or multiple sexual partners
• People with genital symptoms who want a broad workup
• Those without symptoms who want routine sexual health screening
• People whose partner has been diagnosed with a sexually transmitted infection

• A first-catch urine sample is typically needed for trichomoniasis and other urine-based tests
• Avoid urinating for about one to two hours before giving the urine sample when possible
• A blood draw is required for the HIV RNA and hepatitis components
• No fasting is required for this panel

Each component is reported separately. A negative result generally means the specific organism or marker was not detected, while a positive result may indicate exposure or an active infection. Detection windows differ by organism, so a test taken too soon after exposure can miss an infection. Because the panel is a screening tool, results should be interpreted with exposure history and symptoms. Discuss all results with a healthcare provider, who can advise whether additional or repeat testing is needed.

• Alabama
• Alaska
• Arizona
• Arkansas
• California
• Colorado
• Connecticut
• Delaware
• Florida
• Georgia